198 related articles for article (PubMed ID: 23857984)
1. The TAL1 complex targets the FBXW7 tumor suppressor by activating miR-223 in human T cell acute lymphoblastic leukemia.
Mansour MR; Sanda T; Lawton LN; Li X; Kreslavsky T; Novina CD; Brand M; Gutierrez A; Kelliher MA; Jamieson CH; von Boehmer H; Young RA; Look AT
J Exp Med; 2013 Jul; 210(8):1545-57. PubMed ID: 23857984
[TBL] [Abstract][Full Text] [Related]
2. MYCN is a novel oncogenic target in pediatric T-cell acute lymphoblastic leukemia.
Astolfi A; Vendemini F; Urbini M; Melchionda F; Masetti R; Franzoni M; Libri V; Serravalle S; Togni M; Paone G; Montemurro L; Bressanin D; Chiarini F; Martelli AM; Tonelli R; Pession A
Oncotarget; 2014 Jan; 5(1):120-30. PubMed ID: 24334727
[TBL] [Abstract][Full Text] [Related]
3. Regulatory mechanisms and context-dependent roles of TAL1 in T-cell acute lymphoblastic leukemia.
Ong JZL; Tan TK; Wang L; Tan SH; Sanda T
Haematologica; 2024 May; 109(5):1359-1372. PubMed ID: 37855064
[TBL] [Abstract][Full Text] [Related]
4. TAL1 hijacks MYCN enhancer that induces MYCN expression and dependence on mevalonate pathway in T-cell acute lymphoblastic leukemia.
Tan SH; Tan TK; Yokomori R; Liao M; Huang XZ; Yeoh AEJ; Sanda T
Leukemia; 2023 Oct; 37(10):1969-1981. PubMed ID: 37591943
[TBL] [Abstract][Full Text] [Related]
5. S1P-S1PR3-RAS promotes the progression of S1PR3
Zhu D; Jiang T; Ma D; Zhang H; Zhang J; Lv W; Gong M; Wang H; Liu Z; Su H; Zeng L; Liu S; Tang S; Yang B; Tshavuka FI; Fu G; Liu Z; Peng D; Liu H; Yan Z; Cao Z; Zhao H; He TC; Yu J; Shu Y; Zou L
Leukemia; 2023 Oct; 37(10):1982-1993. PubMed ID: 37591940
[TBL] [Abstract][Full Text] [Related]
6. Impact of NOTCH1/FBXW7 mutations on outcome in pediatric T-cell acute lymphoblastic leukemia patients treated on the MRC UKALL 2003 trial.
Jenkinson S; Koo K; Mansour MR; Goulden N; Vora A; Mitchell C; Wade R; Richards S; Hancock J; Moorman AV; Linch DC; Gale RE
Leukemia; 2013 Jan; 27(1):41-7. PubMed ID: 22814294
[TBL] [Abstract][Full Text] [Related]
7. Oncogene regulation. An oncogenic super-enhancer formed through somatic mutation of a noncoding intergenic element.
Mansour MR; Abraham BJ; Anders L; Berezovskaya A; Gutierrez A; Durbin AD; Etchin J; Lawton L; Sallan SE; Silverman LB; Loh ML; Hunger SP; Sanda T; Young RA; Look AT
Science; 2014 Dec; 346(6215):1373-7. PubMed ID: 25394790
[TBL] [Abstract][Full Text] [Related]
8. Integrative network analysis reveals USP7 haploinsufficiency inhibits E-protein activity in pediatric T-lineage acute lymphoblastic leukemia (T-ALL).
Shaw TI; Dong L; Tian L; Qian C; Liu Y; Ju B; High A; Kavdia K; Pagala VR; Shaner B; Pei D; Easton J; Janke LJ; Porter SN; Ma X; Cheng C; Pruett-Miller SM; Choi J; Yu J; Peng J; Gu W; Look AT; Downing JR; Zhang J
Sci Rep; 2021 Mar; 11(1):5154. PubMed ID: 33664368
[TBL] [Abstract][Full Text] [Related]
9. The role of quiescent thymic progenitors in TAL/LMO2-induced T-ALL chemotolerance.
O'Connor KW; Kishimoto K; Kuzma IO; Wagner KP; Selway JS; Roderick JE; Karna KK; Gallagher KM; Hu K; Liu H; Li R; Brehm MA; Zhu LJ; Curtis DJ; Tremblay CS; Kelliher MA
Leukemia; 2024 May; 38(5):951-962. PubMed ID: 38553571
[TBL] [Abstract][Full Text] [Related]
10. The Role of TAL1 in Hematopoiesis and Leukemogenesis.
Vagapova ER; Spirin PV; Lebedev TD; Prassolov VS
Acta Naturae; 2018; 10(1):15-23. PubMed ID: 29713515
[TBL] [Abstract][Full Text] [Related]
11. TLX1 and NOTCH coregulate transcription in T cell acute lymphoblastic leukemia cells.
Riz I; Hawley TS; Luu TV; Lee NH; Hawley RG
Mol Cancer; 2010 Jul; 9():181. PubMed ID: 20618946
[TBL] [Abstract][Full Text] [Related]
12. Direct Phosphorylation and Stabilization of MYC by Aurora B Kinase Promote T-cell Leukemogenesis.
Jiang J; Wang J; Yue M; Cai X; Wang T; Wu C; Su H; Wang Y; Han M; Zhang Y; Zhu X; Jiang P; Li P; Sun Y; Xiao W; Feng H; Qing G; Liu H
Cancer Cell; 2020 Feb; 37(2):200-215.e5. PubMed ID: 32049046
[TBL] [Abstract][Full Text] [Related]
13. Genomic characterization of pediatric T-cell acute lymphoblastic leukemia reveals novel recurrent driver mutations.
Spinella JF; Cassart P; Richer C; Saillour V; Ouimet M; Langlois S; St-Onge P; Sontag T; Healy J; Minden MD; Sinnett D
Oncotarget; 2016 Oct; 7(40):65485-65503. PubMed ID: 27602765
[TBL] [Abstract][Full Text] [Related]
14. The subclonal complexity of STIL-TAL1+ T-cell acute lymphoblastic leukaemia.
Furness CL; Mansur MB; Weston VJ; Ermini L; van Delft FW; Jenkinson S; Gale R; Harrison CJ; Pombo-de-Oliveira MS; Sanchez-Martin M; Ferrando AA; Kearns P; Titley I; Ford AM; Potter NE; Greaves M
Leukemia; 2018 Sep; 32(9):1984-1993. PubMed ID: 29556024
[TBL] [Abstract][Full Text] [Related]
15. NOTCH1-driven UBR7 stimulates nucleotide biosynthesis to promote T cell acute lymphoblastic leukemia.
Srivastava S; Sahu U; Zhou Y; Hogan AK; Sathyan KM; Bodner J; Huang J; Wong KA; Khalatyan N; Savas JN; Ntziachristos P; Ben-Sahra I; Foltz DR
Sci Adv; 2021 Jan; 7(5):. PubMed ID: 33571115
[TBL] [Abstract][Full Text] [Related]
16. ToTAL1y degraded - rapid dTAG proteolysis of TAL1 in T-cell acute lymphoblastic leukemia.
Costa JR; Mansour MR
Haematologica; 2024 May; 109(5):1325-1327. PubMed ID: 38105739
[No Abstract] [Full Text] [Related]
17. Suppression of super-enhancer-driven TAL1 expression by KLF4 in T-cell acute lymphoblastic leukemia.
Noura M; Matsuo H; Yasuda T; Tsuzuki S; Kiyoi H; Hayakawa F
Oncogene; 2024 Feb; 43(6):447-456. PubMed ID: 38102337
[TBL] [Abstract][Full Text] [Related]
18. Oncogenic cooperation between TCF7-SPI1 and NRAS(G12D) requires β-catenin activity to drive T-cell acute lymphoblastic leukemia.
Van Thillo Q; De Bie J; Seneviratne JA; Demeyer S; Omari S; Balachandran A; Zhai V; Tam WL; Sweron B; Geerdens E; Gielen O; Provost S; Segers H; Boeckx N; Marshall GM; Cheung BB; Isobe K; Kato I; Takita J; Amos TG; Deveson IW; McCalmont H; Lock RB; Oxley EP; Garwood MM; Dickins RA; Uyttebroeck A; Carter DR; Cools J; de Bock CE
Nat Commun; 2021 Jul; 12(1):4164. PubMed ID: 34230493
[TBL] [Abstract][Full Text] [Related]
19. Gene expression profiles in BCL11B-siRNA treated malignant T cells.
Huang X; Shen Q; Chen S; Chen S; Yang L; Weng J; Du X; Grabarczyk P; Przybylski GK; Schmidt CA; Li Y
J Hematol Oncol; 2011 May; 4():23. PubMed ID: 21575156
[TBL] [Abstract][Full Text] [Related]
20. CASZ1 upregulates PI3K-AKT-mTOR signaling and promotes T-cell acute lymphoblastic leukemia.
Cardoso BA; Duque M; Gírio A; Fragoso R; Oliveira ML; Allen JR; Martins LR; Correia NC; Silveira AB; Veloso A; Kimura S; Demoen L; Matthijssens F; Jeha S; Cheng C; Pui CH; Grosso AR; Neto JL; De Almeida SF; Van Vlieberghe P; Mullighan CG; Yunes JA; Langenau DM; Pflumio F; Barata JT
Haematologica; 2023 Dec; ():. PubMed ID: 38058200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
